Mechanisms of Small Intestine Involvement in Obesity-Induced Atherosclerosis

References

• Ding S, Lund PK. Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr Opin Clin Nutr Metab Care. 2011;14(4):328–333. doi:10.1097/MCO.0b013e3283478727
   PubMed Web of Science ®Google Scholar
• Piché ME, Tchernof A, Després JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 2020;126(11):1477–1500. doi:10.1161/CIRCRESAHA.120.316101
   PubMed Web of Science ®Google Scholar
• Mozo MV, Finucane FM, Flaherty GT. Health challenges of international travel for obese patients. J Travel Med. 2017;24(6). doi:10.1093/jtm/tax065
   PubMed Web of Science ®Google Scholar
• Pan X, Yue L, Ban J, Ren L, Chen S. Effects of semaglutide on cardiac protein expression and cardiac function of obese mice. J Inflamm Res. 2022;15:6409–6425. doi:10.2147/JIR.S391859
   PubMed Web of Science ®Google Scholar
• Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2021;320(3):C375–C391. doi:10.1152/ajpcell.00379.2020
   PubMed Web of Science ®Google Scholar
• Lovren F, Teoh H, Verma S. Obesity and atherosclerosis: mechanistic insights. Can J Cardiol. 2015;31(2):177–183. doi:10.1016/j.cjca.2014.11.031
   PubMed Web of Science ®Google Scholar
• Curley S, Gall J, Byrne R, Yvan-Charvet L, McGillicuddy FC. Metabolic inflammation in obesity-at the crossroads between fatty acid and cholesterol metabolism. Mol Nutr Food Res. 2021;65(1):e1900482. doi:10.1002/mnfr.201900482
   PubMed Web of Science ®Google Scholar
• Zhang T, Chen J, Tang X, Luo Q, Xu D, Yu B. Interaction between adipocytes and high-density lipoprotein: new insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis. Lipids Health Dis. 2019;18(1):223. doi:10.1186/s12944-019-1170-9
   PubMed Web of Science ®Google Scholar
• Iliodromiti S, Celis-Morales CA, Lyall DM, et al. The impact of confounding on the associations of different adiposity measures with the incidence of cardiovascular disease: a cohort study of 296 535 adults of white European descent. Eur Heart J. 2018;39(17):1514–1520. doi:10.1093/eurheartj/ehy057
   PubMed Web of Science ®Google Scholar
• Inoue KI, Toyoda S, Jojima T, Abe S, Sakuma M, Inoue T. Time-restricted feeding prevents high-fat and high-cholesterol diet-induced obesity but fails to ameliorate atherosclerosis in apolipoprotein E-knockout mice. Exp Anim. 2021;70(2):194–202. doi:10.1538/expanim.20-0112
   PubMed Web of Science ®Google Scholar
• Singer-Englar T, Barlow G, Mathur R. Obesity, diabetes, and the gut microbiome: an updated review. Expert Rev Gastroenterol Hepatol. 2019;13(1):3–15. doi:10.1080/17474124.2019.1543023
   PubMed Web of Science ®Google Scholar
• Dailey MJ. Nutrient-induced intestinal adaption and its effect in obesity. Physiol Behav. 2014;136:74–78. doi:10.1016/j.physbeh.2014.03.026
   PubMed Web of Science ®Google Scholar
• Wan X, Yin J, Chen J. Characteristics of intestinal myoelectrical and motor activities in diet-induced obese rats: obesity and motility. Dig Dis Sci. 2019;64(6):1478–1485. doi:10.1007/s10620-019-5458-4
   PubMed Web of Science ®Google Scholar
• Ye C, Liu L, Ma X, et al. Obesity aggravates acute pancreatitis via damaging intestinal mucosal barrier and changing microbiota composition in rats. Sci Rep. 2019;9(1):69. doi:10.1038/s41598-018-36266-7
   PubMedGoogle Scholar
• Tang WHW, Bäckhed F, Landmesser U, Hazen SL. Intestinal microbiota in cardiovascular health and disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(16):2089–2105. doi:10.1016/j.jacc.2019.03.024
   PubMed Web of Science ®Google Scholar
• Tilg H, Adolph TE, Gerner RR, Moschen AR. The intestinal microbiota in colorectal cancer. Cancer Cell. 2018;33(6):954–964. doi:10.1016/j.ccell.2018.03.004
   PubMed Web of Science ®Google Scholar
• Alvarez-Vieites E, López-Santamarina A, Miranda JM, et al. Influence of the intestinal microbiota on diabetes management. Curr Pharm Biotechnol. 2020;21(15):1603–1615. doi:10.2174/1389201021666200514220950
   PubMed Web of Science ®Google Scholar
• Gomes AC, Hoffmann C, Mota JF. The human gut microbiota: metabolism and perspective in obesity. Gut Microbes. 2018;9(4):308–325. doi:10.1080/19490976.2018.1465157
   PubMed Web of Science ®Google Scholar
• Abenavoli L, Scarpellini E, Colica C, et al. Gut microbiota and obesity: a role for probiotics. Nutrients. 2019;11(11):2690. doi:10.3390/nu11112690
   PubMed Web of Science ®Google Scholar
• Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci. 2020;21(5):1835. doi:10.3390/ijms21051835
   PubMed Web of Science ®Google Scholar
• Williams JW, Winkels H, Durant CP, Zaitsev K, Ghosheh Y, Ley K. Single cell RNA sequencing in atherosclerosis research. Circ Res. 2020;126(9):1112–1126. doi:10.1161/CIRCRESAHA.119.315940
   PubMed Web of Science ®Google Scholar
• Duttaroy AK. Role of gut microbiota and their metabolites on atherosclerosis, hypertension and human blood platelet function: a review. Nutrients. 2021;13(1):144. doi:10.3390/nu13010144
   PubMed Web of Science ®Google Scholar
• Verhaar BJH, Prodan A, Nieuwdorp M, Muller M. Gut microbiota in hypertension and atherosclerosis: a review. Nutrients. 2020;12(10):2982. doi:10.3390/nu12102982
   PubMed Web of Science ®Google Scholar
• Brandsma E, Kloosterhuis NJ, Koster M, et al. A proinflammatory gut microbiota increases systemic inflammation and accelerates atherosclerosis. Circ Res. 2019;124(1):94–100. doi:10.1161/CIRCRESAHA.118.313234
   PubMed Web of Science ®Google Scholar
• Wu M, Yang S, Wang S, et al. Effect of berberine on atherosclerosis and gut microbiota modulation and their correlation in high-fat diet-fed ApoE-/- mice. Front Pharmacol. 2020;11:223. doi:10.3389/fphar.2020.00223
   PubMed Web of Science ®Google Scholar
• Witkowski M, Weeks TL, Hazen SL. Gut microbiota and cardiovascular disease. Circ Res. 2020;127(4):553–570. doi:10.1161/CIRCRESAHA.120.316242
   PubMed Web of Science ®Google Scholar
• Skye SM, Zhu W, Romano KA, et al. Microbial transplantation with human gut commensals containing CutC is sufficient to transmit enhanced platelet reactivity and thrombosis potential. Circ Res. 2018;123(10):1164–1176. doi:10.1161/CIRCRESAHA.118.313142
   PubMed Web of Science ®Google Scholar
• Deng G, Chen Y, Guo C, et al. BMP4 promotes the metastasis of gastric cancer by inducing epithelial-mesenchymal transition via ID1. J Cell Sci. 2020;133(11):jcs237222. doi:10.1242/jcs.237222
   PubMed Web of Science ®Google Scholar
• Jo H, Song H, Mowbray A. Role of NADPH oxidases in disturbed flow- and BMP4- induced inflammation and atherosclerosis. Antioxid Redox Signal. 2006;8(9–10):1609–1619. doi:10.1089/ars.2006.8.1609
   PubMed Web of Science ®Google Scholar
• Vendrov AE, Madamanchi NR, Hakim ZS, Rojas M, Runge MS. Thrombin and NAD(P)H oxidase-mediated regulation of CD44 and BMP4-Id pathway in VSMC, restenosis, and atherosclerosis. Circ Res. 2006;98(10):1254–1263. doi:10.1161/01.RES.0000221214.37803.79
   PubMed Web of Science ®Google Scholar
• Boström K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest. 1993;91(4):1800–1809. doi:10.1172/JCI116391
   PubMed Web of Science ®Google Scholar
• Mu W, Qian S, Song Y, et al. BMP4-mediated browning of perivascular adipose tissue governs an anti-inflammatory program and prevents atherosclerosis. Redox Biol. 2021;43:101979. doi:10.1016/j.redox.2021.101979
   PubMed Web of Science ®Google Scholar
• Shyu HY, Fong CS, Fu YP, et al. Genotype polymorphisms of GGCX, NQO1, and VKORC1 genes associated with risk susceptibility in patients with large-artery atherosclerotic stroke. Clin Chim Acta. 2010;411(11–12):840–845. doi:10.1016/j.cca.2010.02.071
   PubMed Web of Science ®Google Scholar
• Sarutipaiboon I, Settasatian N, Komanasin N, et al. Association of genetic variations in NRF2, NQO1, HMOX1, and MT with severity of coronary artery disease and related risk factors. Cardiovasc Toxicol. 2020;20(2):176–189. doi:10.1007/s12012-019-09544-7
   PubMed Web of Science ®Google Scholar
• Lee WS, Ham W, Kim J. Roles of NAD(P)H: quinone oxidoreductase 1 in diverse diseases. Life. 2021;11(12):1301. doi:10.3390/life11121301
   PubMedGoogle Scholar
• Shukla H, Gaje G, Koucheki A, et al. NADPH-quinone oxidoreductase-1 mediates benzo-[a]-pyrene-1,6-quinone-induced cytotoxicity and reactive oxygen species production in human EA.hy926 endothelial cells. Toxicol Appl Pharmacol. 2020;404:115180. doi:10.1016/j.taap.2020.115180
   PubMed Web of Science ®Google Scholar
• Gum SI, Shin HM, Cho MK. The small GTPases regulate HMC05-induced NQO-1 expression with an antioxidant effect in smooth muscle cells. Biol Pharm Bull. 2014;37(10):1626–1632. doi:10.1248/bpb.b14-00336
   PubMed Web of Science ®Google Scholar
• Aghagolzadeh P, Radpour R, Bachtler M, et al. Hydrogen sulfide attenuates calcification of vascular smooth muscle cells via KEAP1/NRF2/NQO1 activation. Atherosclerosis. 2017;265:78–86. doi:10.1016/j.atherosclerosis.2017.08.012
   PubMed Web of Science ®Google Scholar
• Yan R, Yan J, Chen X, Yu Y, Sun T. Xanthoangelol prevents Ox-LDL-induced endothelial cell injury by activating Nrf2/ARE signaling. J Cardiovasc Pharmacol. 2019;74(2):162–171. doi:10.1097/FJC.0000000000000699
   PubMed Web of Science ®Google Scholar
• Zivkovic M, Bubic M, Kolakovic A, et al. The association of glutathione S-transferase T1 and M1 deletions with myocardial infarction. Free Radic Res. 2021;55(3):267–274. doi:10.1080/10715762.2021.1931166
   PubMed Web of Science ®Google Scholar
• Yang Y, Parsons KK, Chi L, Malakauskas SM, Le TH. Glutathione S-transferase-micro1 regulates vascular smooth muscle cell proliferation, migration, and oxidative stress. Hypertension. 2009;54(6):1360–1368. doi:10.1161/HYPERTENSIONAHA.109.139428
   PubMed Web of Science ®Google Scholar
• de Waart FG, Kok FJ, Smilde TJ, Hijmans A, Wollersheim H, Stalenhoef AF. Effect of glutathione S-transferase M1 genotype on progression of atherosclerosis in lifelong male smokers. Atherosclerosis. 2001;158(1):227–231. doi:10.1016/S0021-9150(01)00420-8
   PubMed Web of Science ®Google Scholar
• García-González I, Pérez-Mendoza G, Solís-Cárdenas A, et al. Genetic variants of PON1, GSTM1, GSTT1, and locus 9p21.3, and the risk for premature coronary artery disease in Yucatan, Mexico. Am J Hum Biol. 2022;34(5):e23701. doi:10.1002/ajhb.23701
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587–D592. doi:10.1093/nar/gkac963
   PubMed Web of Science ®Google Scholar